What the Government Did
The Central government banned a common cold drug combination (chlorpheniramine maleate + phenylephrine hydrochloride) for children under 4 years old.
Drug labels must now carry warnings about risks to young children.
The decision came after expert review showed safer alternatives exist.
Why Paediatricians Support the Ban
Doctors say the combination is unsafe and unnecessary for small children.
Chlorpheniramine (an older antihistamine) can cause sedation and breathing issues.
Phenylephrine (a decongestant) may unpredictably affect heart rate and blood pressure in children.
Safer second-generation antihistamines (like cetirizine, fexofenadine) are available and preferred.
Many childhood coughs and colds are caused by viruses that don’t need medication.
Confusion Among Pharmacists
Pharmacists unsure about what to do with existing stock.
Pharma companies challenged the ban in court; the Delhi High Court ruled:
Ban applies only to new stock after April 15.
Old stock can be sold, but companies must inform chemists and doctors.
Retailers say they’ve not received official instructions and feel unfairly burdened.
Need for Better Communication and Awareness
Doctors urge the government and medical bodies to spread awareness about the ban.
There is a lack of qualified pharmacists and too few drug inspectors to enforce the rules effectively.
Parents should be cautious and avoid using over-the-counter cough syrups without prescription.
For most children, simple remedies like honey and warm water are enough for coughs and colds.
COMMENTS